ResMed(RMD) - 2023 Q2 - Earnings Call Presentation

Three Months Ended Six Months Ended GAAP income from operations Amortization of acquired intangibles—cost of sales (A) Amortization of acquired intangibles—operating expenses (A) Amortization of acquired intangibles—operating expenses, net of tax (A) GAAP diluted shares outstanding (A) ResMed adjusts for the impact of the amortization of acquired intangibles, acquisition-related expenses, and the reserve for disputed tax positions from their evaluation of ongoing operations and believes that investors benef ...